National and international legal definition of medicinal products and innovations in the medical field
DOI:
https://doi.org/10.35774/app2023.04.051Keywords:
international legal definition, medicinal product, innovation, medicine, pharmaceuticals, innovative technologiesAbstract
In the conditions of European integration processes, the medical field, in particular the issue of medicines and innovative medical technologies, plays an important role in social relations. In our time, it is important that the provision of high-quality and effective medicines takes place within the legal framework and is clearly defined by the current legislation of Ukraine and international legal acts, because this is one of the priority issues in the field of health and life protection of the population of Ukraine and other countries.
The International Organization for Economic Cooperation and Development noted that the use of innovative medical technologies and the latest medicines in recent years stimulated progress in the treatment of many diseases and extended people's lives in European countries by 73%. Ukraine’s accession to the World Trade Organization and the signing of the Agreement with the European Union require the state to ensure a balance between the interests of drug manufacturers, innovations and their consumers.
In the modern international legal space, there is no single definition of the concept of «medicine» and «innovation in medicine», which prevents the proper exchange of information and legal regulation of this issue in the legislation of various countries of the world. Therefore, it is important and urgent to determine the concept and content of medicinal products and medical innovations in order to ensure the protection of intellectual property rights in this field, the creation of a single regulatory and legal database that will contribute to the unification of the procedure for patenting, licensing and registration of medicinal products, effective interaction of authorized authorities in the fight against the distribution of falsified and low-quality medicines, counterfeits and other violations and abuses in this area.
The purpose of the article is to analyze existing definitions of the concept and essence of «medicine» and «innovative technologies in the field of medicine» in domestic and foreign legislation, as well as in international legal acts, with the aim of unifying the concepts, finding the most correct recognition that corresponds to and reveals the essence and main content given concepts.
References
Pro likarski zasoby: Zakon Ukrainy vid 4 kvitnia 1996 roku № 123/96-VR v redaktsii vid 13 lystopada 2021 roku [On Medicinal Products: Law of Ukraine of April 4, 1996 № 123/96-VR, as amended on November 13, 2021]. Retrieved from https://zakon.rada.gov.ua/laws/show/123/96-%D0%B2%D1%80#Text [in Ukrainian]
Poriadok provedennia ekspertyzy reiestratsiinykh materialiv na likarski zasoby, shcho podaiutsia na derzhavnu reiestratsiiu (perereiestratsiiu), a takozh ekspertyzy materialiv pro vnesennia zmin do reiestratsiinykh materialiv protiahom dii reiestratsiinoho posvidchennia: zatverdzhenyi nakazom Ministerstva okhorony zdorovia Ukrainy vid 26 serpnia 2005 r. № 426 [Procedure for examination of registration materials for medicinal products submitted for state registration (re-registration), as well as examination of materials on making changes to registration materials during the validity of the registration certificate: approved by order of the Ministry of Health of Ukraine dated August 26, 2005 № 426]. Retrieved from: https://zakon.rada.gov.ua/laws/show/z1069-05#Text [in Ukrainian]
Voronina, I. S. (2015). Pravova kharakterystyka innovatsiinykh likarskykh zasobiv [Legal characteristics of innovative medicinal products]. Pravo ta innovatsii - Law and innovation, 2 (10), 49-54 [in Ukrainian]
Holovenko, M. Ya. (2012). «Filosofiia» farmatsevtychnykh innovatsii [«Philosophy» of pharmaceutical innovations]. Visnyk Natsionalnoi akademii nauk Ukrainy - Bulletin of the National Academy of Sciences of Ukraine, 3, 59-66 [in Ukrainian] https://doi.org/10.15407/visn2012.03.059
Shtryhol, S. Yu. Oryhinalni ta henerychni likarski zasoby [Original and generic drugs]. Retrieved from: http://www.researchgate.net/profile/Olga_Tovchiga /publication/236117563_ BRAND_AND_GENERIC_DRUGS/links/ 0c9605161a 7d4b9535000000.pdf [in Ukrainian]
Pro innovatsiinu diialnist: Zakon Ukrainy vid 4 lypnia 2002 roku № 40-IV [On innovative activity: Law of Ukraine dated July 4, 2002 № 40-IV]. Retrieved from: https://zakon.rada.gov.ua/laws/show/40-15#Text [in Ukrainian]
Kirychenko, I. (2006). Obsiah i zmist prav na obiekty intelektualnoi vlasnosti v haluzi farmatsevtyky, spetsyfichni aspekty zakhystu prav [The scope and content of intellectual property rights in the pharmaceutical, specific aspects of protecting rights]. Retrieved from http://www.justinian.com.ua/article.php?id=2428 [in Ukrainian]
International Society of Drug Bulletins (2001). ISDB Declaration on therapeutic advance in the use of medicines. Paris, France: International Society of Drug Bulletins. Retrieved from http://www.isdbweb.org /documents/uploads/Declaration/ISDB-decl-english.pdf [in English]
Govin Permanand (2006). EU Pharmaceutical Regulation: The Politics of Policy-Making. Manchester University Press [in English]
Vishar, Yu. Yu. (2019). Zakonodavchyi eklektyzm u okhoroni prav na intelektualnyi likprodukt [Legislative eclecticism in the protection of rights to an intellectual medicinal product]. Chasopys Kyivskoho universytetu prava. - Journal of the Kyiv University of Law, 4, 254-262[in Ukrainian].
